Patient factors |
|
Patient exposure to diabetes therapy |
|
|
New to therapy vs. continuing therapy |
0.39 |
0.38, 0.40 |
<0.0001 |
Patient age-group (years) |
|
|
25–44 vs. 45–64 |
0.51 |
0.49, 0.53 |
<0.0001 |
65–74 vs. 45–64 |
1.27 |
1.23, 1.30 |
<0.0001 |
>75 vs. 45–64 |
1.41 |
1.37, 1.44 |
<0.0001 |
Patient sex |
|
|
Male vs. female |
1.14 |
1.12, 1.16 |
<0.0001 |
Patient education |
|
|
Vocational vs. high school equivalent |
1.06 |
0.92, 1.22 |
0.4105 |
College grad vs. high school equivalent |
1.20 |
1.17, 1.23 |
<0.0001 |
Graduate school vs. high school equivalent |
1.41 |
1.36, 1.46 |
<0.0001 |
Patient income |
|
|
$30k to $60k vs. <$30k |
0.93 |
0.91, 0.95 |
<0.0001 |
>$60k vs. <$30k |
1.27 |
1.23, 1.30 |
<0.0001 |
Patient geographic region |
|
|
Midwest vs. West |
1.12 |
1.08, 1.16 |
<0.0001 |
Northeast vs. West |
1.04 |
1.00, 1.08 |
0.0448 |
South vs. West |
1.00 |
0.97, 1.03 |
0.9475 |
Prescription factors |
|
Prescription drug channel: mail vs. retail |
2.09 |
2.04, 2.13 |
<0.0001 |
Total pill burden |
1.22 |
1.21, 1.22 |
<0.0001 |
Out-of-pocket costs (30 days) |
0.89 |
0.89, 0.89 |
<0.0001 |
Prescriber factors |
|
Specialty: endocrinologist vs. primary care |
1.01 |
0.96, 1.07 |
0.6076 |
Specialty: other specialist vs. primary care |
0.91 |
0.89, 0.94 |
<0.0001 |
Prescriber age |
1.002 |
1.002, 1.003 |
0.004 |